Center Book Partners LP Maxcyte, Inc. Transaction History
Center Book Partners LP
- $1.54 Billion
- Q4 2024
A detailed history of Center Book Partners LP transactions in Maxcyte, Inc. stock. As of the latest transaction made, Center Book Partners LP holds 867,009 shares of MXCT stock, worth $3.49 Million. This represents 0.23% of its overall portfolio holdings.
Number of Shares
867,009
Previous 585,086
48.18%
Holding current value
$3.49 Million
Previous $2.28 Million
58.51%
% of portfolio
0.23%
Previous 0.15%
Shares
2 transactions
Others Institutions Holding MXCT
# of Institutions
123Shares Held
69.8MCall Options Held
8.7KPut Options Held
6K-
Cadian Capital Management, LP New York, NY9.34MShares$37.6 Million2.26% of portfolio
-
Black Rock Inc. New York, NY8.14MShares$32.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.43MShares$21.8 Million0.0% of portfolio
-
Vitruvian Partners LLP5.04MShares$20.3 Million18.06% of portfolio
-
Morgan Stanley New York, NY4.41MShares$17.7 Million0.0% of portfolio
About MAXCYTE, INC.
- Ticker MXCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 101,724,000
- Market Cap $409M
- Description
- MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...